Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

(2013) J. S. McLellan et al.   SCIENCE

The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease

(2012) Christine A. Shaw et al.   VACCINE

Animal models of human respiratory syncytial virus disease

(2011) Reinout A. Bem et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses

(2011) Alicia K. Olivier et al.   EXPERIMENTAL LUNG RESEARCH

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

(2011) Peter L. Collins et al.   VIRUS RESEARCH

Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children

(2010) Robert C. Welliver et al.   CURRENT MEDICAL RESEARCH AND OPINION

Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs

(2009) Alicia Olivier et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE